|
URB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.003550E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.846600E-01 |
| Normal-vs-Stage2 |
1.835910E-02 |
| Normal-vs-Stage3 |
1.506780E-01 |
| Normal-vs-Stage4 |
3.256300E-02 |
| Stage1-vs-Stage2 |
3.886300E-02 |
| Stage1-vs-Stage3 |
2.185800E-01 |
| Stage1-vs-Stage4 |
3.988400E-02 |
| Stage2-vs-Stage3 |
4.291600E-01 |
| Stage2-vs-Stage4 |
8.395800E-01 |
| Stage3-vs-Stage4 |
5.584200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.695700E-02 |
| Normal-vs-AfricanAmerican |
8.862200E-01 |
| Normal-vs-Asian |
5.587800E-01 |
| Caucasian-vs-AfricanAmerican |
3.610400E-01 |
| Caucasian-vs-Asian |
8.905000E-01 |
| AfricanAmerican-vs-Asian |
6.132000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.199900E-02 |
| Normal-vs-Female |
4.907000E-01 |
| Male-vs-Female |
2.328600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.034000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.607600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.214300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.252440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.388000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.700200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.282000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.865160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.099400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.061600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.838100E-02 |
| Normal-vs-Grade 2 |
3.960200E-01 |
| Normal-vs-Grade 3 |
9.749500E-02 |
| Normal-vs-Grade 4 |
3.922100E-02 |
| Grade 1-vs-Grade 2 |
8.832200E-02 |
| Grade 1-vs-Grade 3 |
1.688050E-02 |
| Grade 1-vs-Grade 4 |
1.530320E-02 |
| Grade 2-vs-Grade 3 |
3.300600E-01 |
| Grade 2-vs-Grade 4 |
1.469400E-01 |
| Grade 3-vs-Grade 4 |
5.360000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.582800E-01 |
| Normal-vs-ccB subtype |
5.470600E-01 |
| ccA subtype-vs-ccB subtype |
5.545200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.021640E-01 |
| Normal-vs-N1 |
7.674600E-01 |
| N0-vs-N1 |
6.882200E-01 |
|
|
